Clinical trial

Safety and Efficacy of Vilazodone in Major Depressive Disorder

NCT01573598

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE4

Study timeline

Study start (unknown)2012-04-01Date precision: month

Registry last updated2015-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

PlaceboDRUG

VilazodoneDRUG

Sponsors & collaborators

Forest Laboratorieslead sponsor

Mapped research locations

New YorkNew York, United States3 BerlinGermany2 Oklahoma CityOklahoma, United States2 SofiaBulgaria2 BelgradeSerbia2 TurkuFinland2 HoustonTexas, United States1 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 DallasTexas, United States1 San AntonioTexas, United States1 San DiegoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01573598 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.